The FDA kicked off a review process of CBD regulations with a public hearing, but everyone is missing the real story…
On Friday, the FDA held its first-ever public hearing on CBD, and it certainly did not escape media attention.
Headlines ranged from Jezebel’s laughably sensationalistic “Is CBD Over?” to The New York Times’ more serious “Cannabis Companies Push FDA to Ease Rules on CBD Products.”
This hearing, an all-day affair that lasted from 8 a.m. on Friday till 6 p.m., deserves all of the coverage that it’s receiving.
But there’s one thing everyone out there is ignoring.
And it could be exactly the difference needed to push the FDA in the right direction when it comes to CBD regulation.
The Powerful Voice of the People
The hearing featured over 100 speakers, and while that did include a number of representatives from CBD companies attempting to pressure the FDA into loosening its regulations – along with a handful of behind-the-times cannabis dissenters – we also heard from a great number of everyday people.
These individuals spoke of their experiences with CBD products, sharing the profound impact the substance has had on their lives.
In addition to Friday’s speakers, over 900 individuals have made submissions to the hearing’s page on regulations.gov, the online government service that allows the public to participate in the rulemaking process of federal agencies.
This one-of-a-kind cannabis investing tool puts the power to profit directly in your hands. To learn how to get immediate access, just click here.
We took the time to sift through all of these submissions, and we found some truly amazing stories.
And about 10% of those comments came from veterans.
After 22 years serving in two branches of the military in two wars, one such veteran – James P. – was at a loss for how to manage his pain. Opioids were not an option for James, and he endured countless sleepless nights.
Then he found CBD, and “life changed.”
“I use a half dropper twice a day… and I have to set an alarm if I need to be up by 6:00 a.m.,” James said. “My hands, knees, and back are somewhat happy as well.”
Jimmy W. is another veteran whose life has been touched by CBD, and he’s imploring the FDA not to do anything to prevent him from using it.
“I suffer from PTSD and bad flashbacks. I recently started using CBD oil, and it has helped dramatically,” he said. “And now I hear that people want CBD oil took away from us veterans…. Please don’t try and pass any bill banning or taking away the only thing that helps me and millions of other veterans.”
These stories aren’t surprising to us. They’re the same ones we’ve been hearing for a long time, including at the Cannabis Science Conference right here in Baltimore earlier this year.
An interview with Robert Kowalski, Director of Veterans Ending the Stigma.
People are sharing countless stories just like these with the FDA today.
Veterans seeking alternatives to opioids. Parents looking for cures to their children’s seizures. Pet owners trying to alleviate anxiety for the furry members of their families.
Public submissions are still being accepted, and you can read all of these stories – and add your own – by visiting the regulations.gov page for the hearing.
It’s these compelling stories – not the pleading of CBD companies – that will hold the most sway over the FDA as it determines the regulatory future of CBD products.
And once those regulations are finalized, I am confident everyone will know what we’ve known all along – 2019 is the Year of CBD.
A Foregone Conclusion
While the FDA won’t make its final decision until July, other federal bodies are making headway on hemp and CBD regulation.
Last week, the USDA declared that – following the passing of the 2018 Farm Bill – states do not have the authority to prohibit the transportation of hemp across their borders.
And over Memorial Day Weekend, the TSA updated its policies to allow for the carrying of hemp-derived CBD on flights.
Meanwhile, CBD products are continuing to pop up in retail locations across the nation. Here’s a picture I took at my local Wegmans supermarket just this weekend.
As more people encounter these products and discover their incredible benefits, the FDA will have no choice but to allow the public to access CBD.
You need to make sure you know how to play these opportunities before the FDA puts its final stamp of approval on CBD.
Executive Director, National Institute for Cannabis Investors
P.S. The cannabis market saw another big win with Illinois legalizing recreational adult-use cannabis. As the 11th state (plus Washington, D.C.) to legalize recreational cannabis, the market potential could be legendary. As more states legalize and the profit potential grows, the opportunity to get in with a small stake seems less and less likely. That’s why our experts have identified four pot stocks that are each trading under $3 – but have a massive 1,000% profit potential. To learn more about these companies, go here now.
15 responses to “What You Need to Know About the FDA and CBD”
June 04 2019